These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8011845)

  • 21. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients.
    Meira CS; Vidal JE; Costa-Silva TA; Motoie G; Gava R; Hiramoto RM; Pereira-Chioccola VL
    J Immunol Methods; 2013 Sep; 395(1-2):21-8. PubMed ID: 23811152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis.
    Dunlop O; Rootwelt V; Sannes M; Goplen AK; Abdelnoor M; Skaug K; Baklien K; Skar A; Melby K; Myrvang B; Bruun JN
    Scand J Infect Dis; 1996; 28(1):71-3. PubMed ID: 9122637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of the detection of Toxoplasma gondii antigens in AIDS patients.
    Fachado A; Fonte L; Alberti E; Hadad P; Fonseca L; Machin R; Finlay C
    Rev Inst Med Trop Sao Paulo; 1994; 36(6):525-9. PubMed ID: 7569627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral toxoplasmosis and AIDS. Clinical, neuroradiological and immunological findings in 15 patients.
    Orefice G; Carrieri PB; Chirianni A; Rubino S; Liuzzi G; Napolitano G; Rocco A
    Acta Neurol (Napoli); 1992; 14(4-6):493-502. PubMed ID: 1293991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
    Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM
    Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii.
    Zangerle R; Allerberger F
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):207-8. PubMed ID: 8301536
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary prophylaxis against cerebral toxoplasmosis. Efficacy of folinic acid in the prevention of hematologic toxicity of pyrimethamine].
    Brossard G; Neau D; Barbeau P; Pellegrin JL; Leng B
    Presse Med; 1994 Apr; 23(13):613-5. PubMed ID: 8029191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitis.
    Dannemann BR; Israelski DM; Leoung GS; McGraw T; Mills J; Remington JS
    AIDS; 1991 Nov; 5(11):1363-5. PubMed ID: 1768386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin].
    Esvant H; Legoupil I; Gaillat J; Bru JP
    Presse Med; 1993 May; 22(18):877. PubMed ID: 8337221
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus.
    Leport C; Franck J; Chene G; Derouin F; Ecobichon JL; Pueyo S; Miro JM; Luft BJ; Morlat P; Dumon H;
    Clin Diagn Lab Immunol; 2001 May; 8(3):579-84. PubMed ID: 11329461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
    AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A
    Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis.
    Raffi F; Franck J; Pelloux H; Derouin F; Reliquet V; Ambroise-Thomas P; Aboulker JP; Leport C; Dumon H
    Diagn Microbiol Infect Dis; 1999 May; 34(1):51-6. PubMed ID: 10342108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS.
    Monforte AD; Mainini F; Bini T; Moscatelli GC; Antinori S; Formenti T; Testa L; Mena M; Moroni M
    J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150
    [No Abstract]   [Full Text] [Related]  

  • 35. Central nervous system toxoplasmosis in AIDS.
    Bretagne S; Gray F; Costa JM
    N Engl J Med; 1993 May; 328(18):1353-4. PubMed ID: 8469263
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis.
    Contini C; Fainardi E; Cultrera R; Seraceni S; Castellazzi M; Peyron F; Granieri E
    J Neuroimmunol; 2000 Aug; 108(1-2):221-6. PubMed ID: 10900357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cotrimoxazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: a case control study.
    Weigel HM; de Vries E; Regez RM; Henrichs JH; Ten Velden JJ; Frissen PH; van der Meer JT
    Scand J Infect Dis; 1997; 29(5):499-502. PubMed ID: 9435040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal fetal outcome in a pregnancy with central nervous system toxoplasmosis and human immunodeficiency virus infection. A case report.
    Hedriana HL; Mitchell JL; Brown GM; Williams SB
    J Reprod Med; 1993 Sep; 38(9):747-50. PubMed ID: 8254603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A preliminary study of the frequency of focal neurological deficits in HIV/AIDS patients seropositive for Toxoplasma gondii IgG in Lagos, Nigeria.
    Oshinaike OO; Okubadejo NU; Ojini FI; Danesi MA
    Nig Q J Hosp Med; 2010; 20(3):104-7. PubMed ID: 21033315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.